enow.com Web Search

  1. Ads

    related to: generic name for lantus insulin

Search results

  1. Results from the WOW.Com Content Network
  2. Insulin glargine - Wikipedia

    en.wikipedia.org/wiki/Insulin_glargine

    Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. [7] It is injected just under the skin. [7] Effects generally begin an hour after use. [7]

  3. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    Insulin was first used as a medication in Canada by Charles Best and Frederick Banting in 1922. [85] [86] This is a chronology of key milestones in the history of the medical use of insulin. For more details on the discovery, extraction, purification, clinical use, and synthesis of insulin, see Insulin

  4. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Extended insulin zinc insulin (Ultralente) Insulin glargine (Lantus) Insulin detemir (Levemir) Insulin degludec (Tresiba) Insulin degludec is sometimes classed separately as an "ultra-long" acting insulin due to its duration of action of about 42 hours, compared with 24 hours for most other long-acting insulin preparations. [5]

  5. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Generic drug names are given in parentheses following the brand name. – Autoimmune. ... Lantus (insulin glargine), for type 1 and type 2 diabetes mellitus.

  6. List of largest selling pharmaceutical products - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_selling...

    Insulin glargine: Lantus Biologic Diabetes mellitus: Sanofi: 7,029 51 7 Bevacizumab: Avastin ... Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013

  7. Mylan says Sanofi loses Lantus insulin patent claims - AOL

    www.aol.com/news/sanofi-loses-lantus-patent...

    Sanofi is heavily reliant on Lantus, its leading product with sales of 4.62 billion euros ($5.26 billion) in 2017, and Mylan's own insulin drug would be its second competitor after Eli Lilly ...

  8. Price face-off: Generic vs. brand name products - AOL

    www.aol.com/news/2016-03-02-price-face-off...

    View the prices of 10 generic vs. brand name products: More on AOL.com: We're lovin' it: McDonald's slogans over the last five decades The top 15 clothing brands millennials love

  9. Insulin analog - Wikipedia

    en.wikipedia.org/wiki/Insulin_analog

    The onset of action of subcutaneous insulin glargine is somewhat slower than NPH human insulin. It is clear solution as there is no zinc in formula. [7] [better source needed] The biosimilar insulin glargine-yfgn (Semglee) was approved for medical use in the United States in July 2021, [8] and in the European Union in March 2018. [9]

  1. Ads

    related to: generic name for lantus insulin